Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naive Patients with Duchenne Muscular Dystrophy.
Sawnani, H; Horn, PS; Wong, B; Darmahkasih, A; Rybalsky, I; Shellenbarger, KC; Tian, C; Rutter, MM; Simakajornboon, N; Amin, R; et al.
The Journal of Pediatrics.
2019;
210:194-200.e2.
Low bone mineral density and fractures are highly prevalent in pediatric patients with spinal muscular atrophy regardless of disease severity.
Wasserman, HM; Hornung, LN; Stenger, PJ; Rutter, MM; Wong, BL; Rybalsky, I; Khoury, JC; Kalkwarf, HJ.
Neuromuscular Disorders.
2017;
27:331-337.
Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
Wong, BL; Rybalsky, I; Shellenbarger, KC; Tian, C; McMahon, MA; Rutter, MM; Sawnani, H; Jefferies, JL.
The Journal of Pediatrics.
2017;
182:296-303.e1.
Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy.
Tian, C; Wong, BL; Hornung, L; Khoury, JC; Miller, L; Bange, J; Rybalsky, I; Rutter, MM.
Neuromuscular Disorders.
2016;
26:760-767.
The Performance of the Upper Limb scores correlate with pulmonary function test measures and Egen Klassifikation scores in Duchenne muscular dystrophy.
Lee, HN; Sawnani, H; Horn, PS; Rybalsky, I; Relucio, L; Wong, BL.
Neuromuscular Disorders.
2016;
26:264-271.